The Guardian reports: India caps prices on 137 cancer drugs following court ruling
What happened
Following a 2022 legal challenge by a patient unable to afford treatment, the Indian government will implement price caps on 137 cancer drugs starting next month. The move follows a supreme court ruling that classified current industry mark-ups as extortionate.
Why it matters
The policy aims to mitigate the financial burden on patients who previously faced debt or the forced sale of land to afford care. It directly curtails the significant profit margins historically captured by hospitals and pharmacies on these medications.
Bigger picture
This intervention highlights the growing role of judiciary-led mandates in forcing state action to curb healthcare costs and address economic disparities in drug access caused by systemic industry mark-ups.
Watch next
Monitor the implementation next month to see how the hospital and pharmaceutical sectors adjust their pricing models and inventory strategies in response to the caps.